Objectives: Clonal complex (CC) 9 is a prevalent livestock-associated (LA) MRSA clone in Asia whose pathogenicity in humans remains unknown.
Introduction
In addition to being an important medical pathogen, MRSA can also cause diseases in animals and has resulted in economic losses in the livestock production industries. 1, 2 The livestock-associated (LA) MRSA strains present in Europe and North America have been widely disseminated among pigs and veal calves and primarily belong to a prevalent clone referred to as sequence type (ST) 398. [3] [4] [5] Persons in frequent contact with MRSA-colonized animals can also acquire LA-MRSA strains owing to the high rate of carriage in the animals' noses. Colonization by LA-MRSA strains can also occur in persons living in regions with high livestock density but not in direct contact with animals. 5 It was a significant concern when LA-MRSA ST398 strains were reported to be associated with severe infections in humans and outbreaks in healthcare facilities. [6] [7] [8] Thus, the emergence of LA-MRSA ST398 as a human pathogen poses a substantial threat to public health.
Unlike the predominance of LA-MRSA ST398 in Europe and North America, clonal complex (CC) 9 is the predominant LA-MRSA clone in Asian countries, including Taiwan, China, Japan, Thailand and Malaysia. [9] [10] [11] [12] [13] [14] In a nationwide survey of 641 pigs from 22 farms conducted in 2012 in Taiwan, 14.4% of the pigs carried MRSA on their noses and all of the isolates were CC9 strains. 10 The carriage rate for pig farm workers was 19.2%, a rate significantly higher than that (3.8%) for the general Taiwanese population (carrying ST 59 MRSA), and 90% of the carriage isolates were CC9 MRSA. 10, 15 These observations indicate that LA-MRSA CC9 strains are widespread in pigs in Taiwan and are frequently transmitted to persons involved in the pork industry. Despite this prevalence, the pathogenicity of LA-MRSA in humans remains unknown, and to the best of our knowledge, there have been no reports on the detailed characterization of the clinical and molecular features of human infections caused by CC9 strains. In this study, we conducted a national survey to determine the prevalence of MRSA CC9 strains in the clinical setting with the goal of characterizing the phenotypes and delineating the genetic features of CC9 isolates using WGS.
Methods

Ethics
The study was approved by the institutional review board of the Chang Gung Memorial Hospital (reference number: 201600070B0). A waiver of consent was granted given the retrospective nature of the project and anonymous analysis of the clinical information of patients.
Identification of LA-MRSA in the Taiwan Surveillance of Antimicrobial Resistance (TSAR) programme TSAR was a national surveillance programme that monitored the antimicrobial resistance of important medical pathogens isolated from inpatients and outpatients in Taiwan. 16 Clinical isolates were collected in 44 participating hospitals at an interval of 2 years. The slide coagulase test was used for routine identification of Staphylococcus aureus. A negative result in the slide coagulase test was confirmed with the latex agglutination test. Resistance to oxacillin was detected using cefoxitin in the disc diffusion method according to CLSI guidelines. To identify isolates of the Asian LA-MRSA clone, we first screened all MRSA isolates collected in eight rounds of the TSAR between 1998 and 2012 with staphylococcal cassette chromosome mec (SCCmec) typing and spa typing (Supplementary Methods, available as Supplementary data at JAC Online). In our previous work characterizing SCCmec types in LA-MRSA nasal isolates from swine, all isolates harboured an SCCmec V-like element that produced banding patterns after multiplex PCR amplification similar to those of SCCmec type V variants ( Figure S1 ).
10,17
The type V variant (5C2 or 5C2&5) element was found to be common in SCCmec types carried by the epidemic community-associated (CA) MRSA ST59 strains in Taiwan. 18, 19 The spa types of ST59 isolates were collectively termed spa CC437, which included t437, t441, t44 and t976. The isolates with SCCmec type V or V-like element but not belonging to the spa CC437 clone were subject to PFGE typing and MLST (Supplementary Methods).
Isolates of ST9 or its single-locus variants were considered to be of Asian LA-MRSA CC9 and were included for analysis. Clinical information, including demographics, healthcare-associated risks, exposure to livestock, manifestations, treatments and outcomes on the cases with CC9 isolates, was collected by chart review.
Susceptibility testing
The MICs of ciprofloxacin, clindamycin, erythromycin, gentamicin, linezolid, rifampicin, trimethoprim/sulfamethoxazole (SXT), tigecycline and vancomycin were determined using an Etest (bioMérieux) according to the manufacturer's instructions. 
Identification of SCCmec types
The draft genome of each strain was first aligned to the ccr complex of the SCCmec elements of all currently known types (Table S1 ) using BLASTN V R .
21
A draft genome containing fragments with nucleotide identities of .85% was considered to carry the indicated ccr complex and was subsequently aligned to the currently known mec complex (Table S1 ). The SCCmec types were determined based on the composite of the detected ccr and mec complexes. 19 
Phylogenetic analysis
SNPs in the core genome were used to construct the phylogenies of the CC9 MRSA strains. The draft genomes were first aligned to each other with the progressiveMauve procedure and subsequently analysed with the Gubbins program. 22, 23 RAxML was used for phylogenetic tree construction, and the output graphic file was produced with FigTree (http://tree.bio.ed.ac.uk/soft ware/figtree/) and the gubbins_drawer procedure. 23 To clarify the genetic relatedness of the clinical CC9 strains and the strains from livestock, WGS of five ST9 nasal isolates from pigs (Table S2 ) and draft genome data for a ST9 bovine mastitis strain (BA01611) were included for analysis. The genome of BA01611 was downloaded from the GenBank database (accession numbers LIRC01000001-LIRC01000050). The strain was isolated from a milk sample of a Holstein cow with clinical mastitis in northwest China. It belonged to spa type t899 and exhibited resistance to oxacillin, kanamycin, gentamicin, penicillin, erythromycin, cefoxitin, neomycin, chloramphenicol and sulfamethoxazole.
Toxome profiles and resistance gene profiles
A subset of genes encoding the important virulence molecules in S. aureus were assembled and aligned with the draft genomes using BLAST V R . 21 The accession numbers of the query virulence genes are provided in Table S3 . The resistance genes were detected by the srst2 software using the ARG-ANNOT database.
24,25
Statistics
The descriptive statistics were analysed with SAS 9.3 software (SAS Institute Inc., Cary, NC) for Windows.
Results
First identified case with LA-MRSA CC9 infection
In 2012, a 57 year old pig slaughterer and pork retailer accidentally cut his left thumb with a butcher's knife (case 09, Table 1 ). The wound was complicated by MRSA cutaneous abscess and osteomyelitis (strain QR502, Table 2 ). Determination of the molecular features of two serial MRSA isolates disclosed that both isolates were ST9, spa type t899 and carried a not yet defined SCCmec element, which was consistent with the characteristics of the major LA-MRSA clones in Taiwan. 9, 10, 17 The electrophoresis band patterns of the SmaI-digested chromosomal DNA in the two clinical ST9 isolates were very similar to those of the representative carriage strains from pigs and pig farm workers in the 2012 survey ( Figure S2 ).
CC9 strains in clinical MRSA isolates in Taiwan
To determine whether CC9 LA-MRSA has emerged as clinical MRSA isolates, we screened a total of 3328 MRSA isolates in the TSAR database collected from 1998 to 2012. In total, eight MRSA isolates were confirmed to be of CC9 (ST9 or its single-locus variant ST2343) ( Table 2) . Together with the isolate from case 09, nine CC9 clinical isolates were collected from seven hospitals around the island over 14 years (Figure 1 ). The earliest isolate was identified in central Taiwan in 1998 (case 01, Table 1 ). Of the nine isolates, four were associated with invasive infections, including osteomyelitis in two cases and bacteraemia in the other two cases. The two bacteraemic cases had multiple comorbidities, and the blood cultures were positive for MRSA upon admission to the hospital, indicating community-onset (CO) infection. Both patients died of severe MRSA sepsis despite aggressive antibiotic treatment. Clinical information was not available for case 03. The other three isolates (cases 04, 05 and 08) were associated with either relatively mild disease or colonization (case 05), and the patients recovered uneventfully. In addition to case 09, history of exposure to pigs was identified in case 08, who was previously healthy and worked on a pig farm before developing bursitis of the knee. Occurrence of the infection before 48 h of admission in patients without HA risk was considered CA, whereas in patients with HA risk this was considered CO with HA risk. Infection beyond 48 h of admission was defined as HA. Human cases of LA-MRSA ST9
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Characteristics of clinical LA-MRSA CC9 strains
The genotypic features and antibiograms of the studied strains are displayed in Table 2 . The PFGE grouped the isolates into two major types ( Figure 2 ).
Mapping of SCCmec elements disclosed that two SCCmec type V variant strains revealed by multiplex PCR carried a type V T element ( Figure 3) . The remaining seven strains harboured a ccr C2 gene complex and a mec C2 gene complex with 99%-100% homology to that of a recently identified novel SCCmec element (designated as type XII) in the ST9 bovine mastitis strain BA01611. 26 Further analysis of the SCCmec structures in the seven strains revealed that all the strains harboured a DccrA1-containing pseudo SCC element that shared 99% nucleotide identity to the wSCC BA01611 in strain BA01611. These data clearly demonstrated that, except for two strains (TSAR01 and TSAR05), the majority of the clinical LA-MRSA CC9 strains harboured an SCCmec XII element with the same structural organization as that in bovine strain BA01611 from China ( Table 2 ). This finding suggests there is genetic relatedness between clinical CC9 strains found in Taiwan and ST9 strains isolated from livestock in China.
This assumption was supported by the results of phylogenetic analysis of the WGS data corresponding to the strains. Multiple likelihood analysis of SNPs in core genomes divided the CC9 strains into two clades (clade I and II, Figure 4 ). There were ,200 SNPs in strains within the same clade, whereas .1000 SNPs were identified in strains of different clades ( Figure S3 ). The bovine isolate (BA01611) and five swine isolates were phylogenetically related to the clinical strains in clade I.
The distributions of the virulence and resistance genes carried in the strains are displayed in Table 3 . Consistent with the results of the phylogenetic analysis, the CC9 strains from the two clades harboured distinct toxome profiles and resistance profiles. Of note, a truncated hlb gene and the sak, sep and scn genes were detected in clade II strains, suggesting these strains carried an hlb-converting prophage containing an immune evasion cluster. 27 The seven strains in clade I harboured an intact hlb gene and lacked any known virulence genes encoding immune evasion molecules. 28, 29 The resistance genes were more commonly identified in strains of clade I compared with strains TSAR01 and TSAR05 (clade II) ( Table 3) . . PFGE patterns of nine clinical CC9 MRSA isolates. Strains TSAR01 and 05 belonged to the same pulsotype and were distinguishable from the other seven strains (TSAR02, 03, 04, 06, 07, 08 and QR502). Clustering was performed using the Dice similarity coefficient and the unweighted pair group method with arithmetic means (UPGMA) with 1.1% of tolerance and 0% optimization.
Chen et al.
The MRSA CC9 strains exhibited high rates of resistance to nonb-lactams, including ciprofloxacin (8/9, 88.9%), erythromycin (8/9, 88.9%), clindamycin (7/9, 77.8%), gentamicin (7/9, 77.8%) and tigecycline (7/9, 77.8%), but they were fully (100%) susceptible to rifampicin, linezolid and vancomycin. Resistance to SXT was identified in one isolate (11.1%). Consistent with the finding in resistance gene profiles, the number of non-b-lactams to which the strains were resistant was significantly greater for the strains in clade I than those in clade II (median number, 6 versus 1.5, P " 0.0004, Wilcoxon rank sum test, Table 2 ).
Discussion
ST398 LA-MRSA can cause a variety of severe infections, including bacteraemia, pneumonia and osteoarticular infections, in humans. 1 To the best of our knowledge, ST9 MRSA-associated Human cases of LA-MRSA ST9 JAC human diseases have not been previously reported to have a direct connection to pigs. In the current study, two patients (cases 08 and 09) had a history of exposure to pigs before the development of MRSA CC9 infections. The isolate (QR502) from case 09 shared very similar electrophoresis band patterns to representative carriage strains circulating in pigs and pig farmers in Taiwan ( Figure S2 ). Phylogenetic analysis of WGS data further demonstrated the close genetic relatedness of seven clinical CC9-SCCmecXII strains and a bovine strain (BA01611) found in China. Together, these data indicate that common interspecies /allele BA01611  TSAR01  TSAR02  TSAR03  TSAR04  TSAR05  TSAR06  TSAR07  TSAR08 An asterisk indicates an allele with two separated fragments located in different scaffolds of draft genomes, suggesting a truncated allele. c For resistance alleles, a shaded cell indicates presence of the allele that was detected by srst2 software using the ARG-ANNOT database.
transmission of CC9 strains occurs between animals and humans. The study further highlighted that, similar to the ST398 strains, the prevalent LA-MRSA CC9 strains in Asia could also cause severe and even lethal human diseases. The frequent spread of LA-MRSA strains to humans and their characteristic high rates of resistance to multiple antimicrobial agents of different classes are particularly worrisome. Although the disease prevalence remains low, emerging infections caused by LA-MRSA strains pose a threat to public health and should not be overlooked.
Although a previous study of ST398-dominant LA-MRSA strains show less efficiency for human-to-human transmission of LA-MRSA strains compared with MRSA strains of other genotypes, 30 the capability of CC9 to undergo transmission between humans was not reported. Seven of the nine patients in the current study had no recorded exposure history to livestock, and the acquisition of the strains from other sources cannot be completely ruled out. Indeed, healthcare-associated risks were identified in five of the seven patients (Table 1) . It is possible that the healthcare environment, medical personnel, or resident patients might have been the sources of the CC9 MRSA strains. Given the high frequency of horizontal transfer of genetic material imparting drug resistance between different S. aureus strains, attempts should be made to detect multiresistant MRSA CC9 strains in healthcare facilities. Continuous monitoring of the molecular epidemiology of MRSA infections in hospitals and communities coupled with effective control measures would help confine the spread of multiresistant LA-MRSA strains.
Characterization of the clinical LA-MRSA CC9 strains using a variety of molecular methods along with WGS clearly revealed two clades (subtypes), respectively with SCCmecXII and SCCmecV T . The SCCmecV T -carrying CC9 strains studied here were phylogenetically distant from the assessed SCCmecXII strains by .1000 nucleotide variations in the core genome and harboured b-haemolysin-converting immune evasion molecules, which were absent from the SCCmecXII strains. SCCmecV T was prevalent in an epidemic clone (ST59) of community-associated MRSA that has been found in Asia and Taiwan. Complete sequencing of the SCCmec elements in two CC9 strains revealed that type V T differed from type V by carrying an extra ccrC complex (5C2&5). The type V T strains also exhibited general susceptibility to non-b-lactams, a characteristic typical of CA-MRSA strains. The data suggested that the CC9-SCCmecV T might be a more 'human-adapted' or 'community-adapted' subtype. On the contrary, all of the five ST9 isolates from animals were multidrug resistant and belonged to the SCCmecXII clade, suggesting a 'livestock-adapted' subtype of this clone. It is intriguing to note that the presence of two different host-specific subpopulations has also been identified in the ST398 lineage.
31 CC9 MRSA strains from pigs or pig farmers have also been reported to be associated with SCCmecIVb or V in Hong Kong, SCCmecV in Malaysia, SCCmecIX in Thailand and SCCmecXIc in Taiwan. 9, 13, 14, 32 Together, these data indicate that the circulating CC9 strains in Asia were of multiple subtypes originating from different ancestors. The common horizontal acquisition of mobile genetic elements, including SCC elements and drug resistance genes in S. aureus strains of the ST9 background, may play an important role in the evolution of the prevalent LA-MRSA clone in Asia. 26 The strains carrying SCCmecXII were resistant to multiple nonb-lactams, showing universal resistance to ciprofloxacin, clindamycin, erythromycin, gentamicin and tigecycline and high rates of resistance to quinupristin/dalfopristin. This multiresistance might be explained by the use of common antimicrobial agents in livestock production in Asian countries. Indeed, the level of antimicrobial agents consumed in Taiwan was estimated to be 2.76-fold greater in food animals than in humans. 33 The strains remained fully susceptible to anti-MRSA antibiotics of last resort, including vancomycin and linezolid, and showed a high incidence of susceptibility to rifampicin and trimethoprim/sulfamethoxazole. Thus, antimicrobiograms should be considered in the management of putative staphylococcal disease in patients at risk of LA-MRSA colonization/infection in the endemic area.
In conclusion, LA-MRSA CC9 strains prevalent in pigs in Asia have emerged as human pathogens capable of causing severe and lethal diseases. The strains examined here carried a novel SCCmecXII element and exhibited extremely high rates of resistance to multiple antimicrobial agents of different classes. Thus, the choice of empirical antibiotics for putative staphylococcal disease should be more meticulous in the endemic region of LA-MRSA CC9. It is also critical to continuously monitor the local epidemiology of MRSA and implement effective control measures to limit the spread of LA-MRSA between animals, to humans and in healthcare facilities.
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